P1.13: Quality of life among breast canc
β
Volker Arndt; Henrike Merx; Til StΓΌrmer; Christa Stegmaier; Hartwig Ziegler; Her
π
Article
π
2004
π
John Wiley and Sons
π
English
β 75 KB
π 3 views
Quality of life (QOL) has become an important outcome measure in the treatment of cancer patients. QOL mainly has been assessed in clinical trials within selective cancer populations to evaluate the effects of specific therapeutic procedures, whereas comparative analyses with QOL of population-based